Caitlin Raymond: Why Transfusion Medicine Should Be Looped in Early in Transfusion Reactions
Caitlin Raymond, Assistant Professor of Pathology and Transfusion Medicine at the University of Wisconsin-Madison, shared a post on LinkedIn:
“Many clinicians don’t realize that the blood bank has its own physician-led consult service available 24/7, aka Transfusion Medicine.
In many hospitals, the blood bank laboratory and the Transfusion Medicine service operate as one integrated safety system — but they serve different functions.
The lab ensures:
- Compatibility
- Product preparation
- Regulatory compliance
Transfusion Medicine provides:
- Real-time clinical judgment
- Reaction evaluation
- Risk–benefit consultation
- Hemovigilance oversight
When a patient develops hypoxia, hypotension, or fever during a transfusion, the question shifts from ‘What do the labs show?’ to ‘Is this TRALI? TACO? Hemolysis? Sepsis? Something else?’
That distinction between laboratory information and clinical judgement matters, both for the patient in front of you and for the integrity of hospital safety data.
I wrote about our complimentary roles in patient safety, and why Transfusion Medicine should be looped in early in transfusion reactions.”

Other posts featuring Caitlin Raymond on Hemostasis Today.
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs